Average Co-Inventor Count = 2.68
ph-index = 26
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. National Institutes of Health, a Component of the US Dept. of Health & Human Services (117 from 3,435 patents)
2. The United States of America As Represented by the Department of Health (12 from 1,215 patents)
3. University of Minnesota (11 from 2,304 patents)
4. Intima Bioscience, Inc. (11 from 13 patents)
5. Kite Pharma, Inc. (6 from 41 patents)
6. Other (4 from 832,680 patents)
7. The United States of America As Represented by the Secretary of (2 from 2,202 patents)
8. Yeda Research and Development Co. Ltd. (1 from 1,167 patents)
9. Immunocore Limited (1 from 45 patents)
10. Wilson Wolf Manufacturing Corporation (1 from 33 patents)
11. The Government of the United States of America, As Represented by the (1 from 28 patents)
12. Therion Biologics Corporation (1 from 15 patents)
13. The United States of America As Represented by the Secretary, Department (1 from 13 patents)
14. The United States of America, As Represented by the Secretary, Department of Health and Human Service (1 from 1 patent)
15. The Government of the United States of America (12 patents)
139 patents:
1. 12458654 - Methods of conditioning patients for T cell therapy
2. 12448428 - HLA class II-restricted t cell receptors against RAS with G12R mutation
3. 12441778 - T cell receptors recognizing HLA-A1-restricted MAGE-A3
4. 12404317 - T cell receptors recognizing MHC class II-restricted MAGE-A3
5. 12391742 - Anti-KRAS-G12D T cell receptors
6. 12304940 - HLA class II-restricted t cell receptors against mutated RAS
7. 12227554 - Methods for selectively expanding cells expressing a TCR with a murine constant region
8. 12221627 - Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells
9. 12187779 - Anti-human papillomavirus 16 E6 T cell receptors
10. 12171818 - Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
11. 11976299 - Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
12. 11939365 - T cell receptors recognizing mutated P53
13. 11925664 - Intracellular genomic transplant and methods of therapy
14. 11918640 - Methods of preparing anti-human papillomavirus antigen T cells
15. 11903966 - Intracellular genomic transplant and methods of therapy